Welcome to our dedicated page for Standard Dental Labs SEC filings (Ticker: TUTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standard Dental Labs Inc. (TUTH) SEC filings page on Stock Titan is designed to help investors and researchers review the company’s regulatory disclosures in one place. Standard Dental Labs is a Florida-based consolidator of independent dental laboratories, and its filings provide context on how it pursues acquisitions, structures its capital, and supports its roll-up strategy in the dental laboratory sector.
Although recent company communications highlight milestones such as SEC qualification of its Form 1-A Regulation A offering, name and ticker changes, and a reverse stock split, the detailed terms and risk factors associated with these actions are typically set out in formal SEC documents. On this page, users can access filings such as offering statements and related materials when they are available through the EDGAR system.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language. For lengthy documents, the platform highlights key topics such as acquisition structures, use of proceeds for purchasing additional dental laboratories in Florida, and descriptions of the company’s strategy to standardize digital workflows and centralize production. Where applicable, users can also review ownership and insider activity through forms that report share transactions by directors and significant shareholders.
Filings like annual and quarterly reports, when available, can provide additional detail on Standard Dental Labs’ acquisition pipeline, integration progress, and financial reporting related to its consolidation model. With real-time updates from EDGAR and AI-generated insights, this page offers a structured way to examine how TUTH describes its business, capital structure, and risks in official regulatory documents.
Standard Dental Labs Inc. reported a private financing transaction involving a convertible note. On January 21, 2025, the company issued a convertible note with a principal amount of $200,000 to an existing investor, receiving $200,000 in cash proceeds.
Ninety days after issuance, the note’s principal plus any accrued and unpaid interest may be converted, at the holder’s option, into shares of the company’s common stock at a conversion price of $0.06 per share. The securities were issued in a private offering under Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.
Standard Dental Labs Inc. updated investors on its planned acquisition of certain assets from Dream Dentistry Labs, LLC. The company previously agreed to buy these assets for total consideration of